Cargando…
Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium
Advances in drug research not only depend on high throughput screening to evaluate large numbers of lead compounds but also on the development of in vitro models which can simulate human tissues in terms of drug permeability and functions. Potential failures, such as poor permeability or interaction...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524416/ https://www.ncbi.nlm.nih.gov/pubmed/31133850 http://dx.doi.org/10.3389/fphar.2019.00456 |
_version_ | 1783419557568839680 |
---|---|
author | Patient, Jamie D. Hajiali, Hadi Harris, Kate Abrahamsson, Bertil Tannergren, Christer White, Lisa J. Ghaemmaghami, Amir M. Williams, Philip M. Roberts, Clive J. Rose, Felicity R. A. J. |
author_facet | Patient, Jamie D. Hajiali, Hadi Harris, Kate Abrahamsson, Bertil Tannergren, Christer White, Lisa J. Ghaemmaghami, Amir M. Williams, Philip M. Roberts, Clive J. Rose, Felicity R. A. J. |
author_sort | Patient, Jamie D. |
collection | PubMed |
description | Advances in drug research not only depend on high throughput screening to evaluate large numbers of lead compounds but also on the development of in vitro models which can simulate human tissues in terms of drug permeability and functions. Potential failures, such as poor permeability or interaction with efflux drug transporters, can be identified in epithelial Caco-2 monolayer models and can impact a drug candidate’s progression onto the next stages of the drug development process. Whilst monolayer models demonstrate reasonably good prediction of in vivo permeability for some compounds, more developed in vitro tools are needed to assess new entities that enable closer in vivo in vitro correlation. In this study, an in vitro model of the human intestinal epithelium was developed by utilizing nanofibers, fabricated using electrospinning, to mimic the structure of the basement membrane. We assessed Caco-2 cell response to these materials and investigated the physiological properties of these cells cultured on the fibrous supports, focusing on barrier integrity and drug-permeability properties. The obtained data illustrate that 2D Caco-2 Transwell(®) cultures exhibit artificially high trans-epithelial electrical resistance (TEER) compared to cells cultured on the 3D nanofibrous scaffolds which show TEER values similar to ex vivo porcine tissue (also measured in this study). Furthermore, our results demonstrate that the 3D nanofibrous scaffolds influence the barrier integrity of the Caco-2 monolayer to confer drug-absorption properties that more closely mimic native gut tissue particularly for studying passive epithelial transport. We propose that this 3D model is a suitable in vitro model for investigating drug absorption and intestinal metabolism. |
format | Online Article Text |
id | pubmed-6524416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65244162019-05-27 Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium Patient, Jamie D. Hajiali, Hadi Harris, Kate Abrahamsson, Bertil Tannergren, Christer White, Lisa J. Ghaemmaghami, Amir M. Williams, Philip M. Roberts, Clive J. Rose, Felicity R. A. J. Front Pharmacol Pharmacology Advances in drug research not only depend on high throughput screening to evaluate large numbers of lead compounds but also on the development of in vitro models which can simulate human tissues in terms of drug permeability and functions. Potential failures, such as poor permeability or interaction with efflux drug transporters, can be identified in epithelial Caco-2 monolayer models and can impact a drug candidate’s progression onto the next stages of the drug development process. Whilst monolayer models demonstrate reasonably good prediction of in vivo permeability for some compounds, more developed in vitro tools are needed to assess new entities that enable closer in vivo in vitro correlation. In this study, an in vitro model of the human intestinal epithelium was developed by utilizing nanofibers, fabricated using electrospinning, to mimic the structure of the basement membrane. We assessed Caco-2 cell response to these materials and investigated the physiological properties of these cells cultured on the fibrous supports, focusing on barrier integrity and drug-permeability properties. The obtained data illustrate that 2D Caco-2 Transwell(®) cultures exhibit artificially high trans-epithelial electrical resistance (TEER) compared to cells cultured on the 3D nanofibrous scaffolds which show TEER values similar to ex vivo porcine tissue (also measured in this study). Furthermore, our results demonstrate that the 3D nanofibrous scaffolds influence the barrier integrity of the Caco-2 monolayer to confer drug-absorption properties that more closely mimic native gut tissue particularly for studying passive epithelial transport. We propose that this 3D model is a suitable in vitro model for investigating drug absorption and intestinal metabolism. Frontiers Media S.A. 2019-05-10 /pmc/articles/PMC6524416/ /pubmed/31133850 http://dx.doi.org/10.3389/fphar.2019.00456 Text en Copyright © 2019 Patient, Hajiali, Harris, Abrahamsson, Tannergren, White, Ghaemmaghami, Williams, Roberts and Rose. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Patient, Jamie D. Hajiali, Hadi Harris, Kate Abrahamsson, Bertil Tannergren, Christer White, Lisa J. Ghaemmaghami, Amir M. Williams, Philip M. Roberts, Clive J. Rose, Felicity R. A. J. Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium |
title | Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium |
title_full | Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium |
title_fullStr | Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium |
title_full_unstemmed | Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium |
title_short | Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium |
title_sort | nanofibrous scaffolds support a 3d in vitro permeability model of the human intestinal epithelium |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524416/ https://www.ncbi.nlm.nih.gov/pubmed/31133850 http://dx.doi.org/10.3389/fphar.2019.00456 |
work_keys_str_mv | AT patientjamied nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium AT hajialihadi nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium AT harriskate nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium AT abrahamssonbertil nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium AT tannergrenchrister nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium AT whitelisaj nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium AT ghaemmaghamiamirm nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium AT williamsphilipm nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium AT robertsclivej nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium AT rosefelicityraj nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium |